2021 wasn't the best year for gene-editing stocks, but expect a comeback in 2022. Here's the top gene-editing choice for next year. More
Articles
The Bullish Case for Ethereum Hinges on the Answer to One Question
An on-time launch of Ethereum 2.0 will be a catalyst for Ethereum in 2022. However, with monetary policy tightening, will investors move away from risk-on assets. More
Cardano’s Downward Spiral May Be Over as It Appears to Reach a Trough
Cardano is down 60% peak-to-trough -- similar to last year -- and appears to be oversold, so expect a rebound going forward. More
Crypto.com Coin Price Predictions: How High Will Staples Center Name Change Take CRO?
Crypto.com Coin price predictions are on everybody's mind today as investors anticipate a price boom on Saturday via Crypto.com Arena. More
NFTs Are Transforming Music. Artists and Investors Can Profit.
Music NFTs are changing the ways artists connect with their fans. The changing marketplace has created new opportunities to profit. More
Stay Away From Floki Inu Despite Positive Recent Developments
Floki Inu is gaining ground because of its upcoming involvement in the Metaverse. But it needs more legs to stand on beyond this catalyst. More
Polestar and Gores Guggenheim Stock Both Fail to Stand Out
The Polestar 2's lack of distinction and awkward pricing may spell trouble for GGPI stock, which is why I'll be waiting on the sidelines. More
